Inventor
ELBASHIR SAYDA M
US27 patents
⚠️ This page may combine multiple inventors who share the name “ELBASHIR SAYDA M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MODERNATX INC
13 patentsUS9533047B2Jan 3, 2017
Delivery and formulation of engineered nucleic acids
MODERNATX INC101 citations99
US10898574B2Jan 26, 2021
Delivery and formulation of engineered nucleic acids
MODERNATX INC50 citations98
US10772975B2Sep 15, 2020
Modified Polynucleotides for the production of biologics and proteins associated with human disease
MODERNATX INC37 citations98
US9950068B2Apr 24, 2018
Delivery and formulation of engineered nucleic acids
MODERNATX INC18 citations94
US9814760B2Nov 14, 2017
Modified polynucleotides for the production of biologics and proteins associated with human disease
MODERNATX INC15 citations92
US12364763B2Jul 22, 2025
Delivery and formulation of engineered nucleic acids
MODERNATX INC2 citations86
US11911474B2Feb 27, 2024
Delivery and formulation of engineered nucleic acids
MODERNATX INC4 citations86
US9828416B2Nov 28, 2017
Modified polynucleotides for the production of secreted proteins
MODERNATX INC3 citations84
US9701965B2Jul 11, 2017
Engineered nucleic acids and methods of use thereof
MODERNATX INC4 citations82
US12502431B2Dec 23, 2025
Delivery and formulation of engineered nucleic acids
MODERNATX INC0 citations63
US12419957B2Sep 23, 2025
Delivery and formulation of engineered nucleic acids
MODERNATX INC0 citations63
US12409226B2Sep 9, 2025
Delivery and formulation of engineered nucleic acids
MODERNATX INC0 citations63
US11603399B2Mar 14, 2023
Long-lived polynucleotide molecules
MODERNATX INC0 citations62
MODERNA THERAPEUTICS INC
8 patentsUS9587003B2Mar 7, 2017
Modified polynucleotides for the production of oncology-related proteins and peptides
MODERNA THERAPEUTICS INC67 citations99
US9572896B2Feb 21, 2017
In vivo production of proteins
MODERNA THERAPEUTICS INC75 citations99
US9254311B2Feb 9, 2016
Modified polynucleotides for the production of proteins
MODERNA THERAPEUTICS INC126 citations99
US9221891B2Dec 29, 2015
In vivo production of proteins
MODERNA THERAPEUTICS INC113 citations99
US9572897B2Feb 21, 2017
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
MODERNA THERAPEUTICS INC65 citations98
US9504734B2Nov 29, 2016
Modified polynucleotides for the production of nuclear proteins
MODERNA THERAPEUTICS INC56 citations98
US9827332B2Nov 28, 2017
Modified polynucleotides for the production of proteins
MODERNA THERAPEUTICS INC7 citations84
US9782462B2Oct 10, 2017
Modified polynucleotides for the production of proteins associated with human disease
MODERNA THERAPEUTICS INC7 citations84
modeRNA Therapeutics
5 patentsUS9186372B2Nov 17, 2015
Split dose administration
modeRNA Therapeutics86 citations99
US8999380B2Apr 7, 2015
Modified polynucleotides for the production of biologics and proteins associated with human disease
modeRNA Therapeutics258 citations98
US8680069B2Mar 25, 2014
Modified polynucleotides for the production of G-CSF
modeRNA Therapeutics180 citations98
US8754062B2Jun 17, 2014
DLIN-KC2-DMA lipid nanoparticle delivery of modified polynucleotides
modeRNA Therapeutics204 citations97
US8664194B2Mar 4, 2014
Method for producing a protein of interest in a primate
modeRNA Therapeutics90 citations97